Skip to main content
Avanti Feeds ltd. logo

Avanti Feeds ltd. — Investor Relations & Filings

Ticker · AVANTIFEED ISIN · INE871C01038 LEI · 335800USE8T3G88KN868 BSE.NS Manufacturing
Open in API
Filings indexed 1,317 across all filing types
Latest filing 2025-02-22 Investor Presentation
Country IN India
Listing BSE.NS AVANTIFEED

About Avanti Feeds ltd.

https://avantifeeds.com

Avanti Feeds Ltd. specializes in the production of high-quality shrimp feed and the processing and export of shrimp. The company operates through a strategic technical and financial collaboration with Thai Union Group. Its product portfolio includes a diverse range of scientifically formulated shrimp feeds designed for various growth stages and species, such as Black Tiger and Vannamei. In addition to feed manufacturing, the company maintains advanced shrimp processing facilities that adhere to international quality standards, catering to global markets including the United States, Europe, and Japan. Avanti Feeds focuses on providing holistic support to the aquaculture community through technical services and sustainable farming practices. Its vertically integrated business model ensures traceability and quality control throughout the value chain, from feed production to the final processed product.

Recent filings

Filing Released Lang Actions
Investors Presentation Q3 & 9M FY25
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation for Q3 & Nine Months ended for FY2025 results" and is addressed to stock exchanges referencing SEBI regulations. It contains detailed financial data including quarterly and nine-month consolidated highlights, segment revenues, EBITDA, PAT, EPS, operational highlights, and management commentary. The content is structured as a presentation with slides covering financial results, operational metrics, and outlook. The document length is about 15,000 characters, indicating a full presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or an interim report with full financial statements, but rather a detailed investor presentation focusing on quarterly and nine-month results. Therefore, the document fits the category of an Investor Presentation (IP).
2025-02-22 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Investor Presentation for Q3 & Nine Months ended for FY2025 results" and is addressed to stock exchanges with reference to a conference call schedule. It contains detailed financial data including quarterly and nine-month consolidated highlights, segment revenues, EBITDA, PAT, EPS, operational highlights, and management commentary. The content is typical of a presentation prepared for investors focusing on financial results, business performance, and outlook. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement or a full annual or quarterly report. There is no indication that this is a full annual report (10-K) or an interim report (IR) with full financial statements, but rather a presentation summarizing the quarterly and nine-month results. Therefore, the appropriate classification is Investor Presentation (IP).
2025-02-22 English
Intimation of schedule of Investors conference (i.e. Group Meet) Call for Quarter and Nine Months ended December 31, 2024.
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about the schedule of an investors conference call to discuss the unaudited financial results for the quarter and nine months ended December 31, 2024. It includes details of the conference call such as date, time, senior management participants, and dial-in numbers. The document does not contain actual financial statements or detailed financial analysis but is an announcement of the upcoming earnings call event. Therefore, it is best classified as a Call Transcript (CT) announcement or related to the earnings call. However, since this is a notice of the conference call schedule and invitation, not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the call. The document length is under 5,000 characters and does not contain the transcript or financial data itself, so it is not an Earnings Release (ER) or Call Transcript (CT).
2025-02-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter to stock exchanges about the schedule of an investors conference call to discuss the unaudited financial results for the quarter and nine months ended December 31, 2024. It includes details about the date, time, senior management participants, and dial-in numbers for the audio conference call. There are no actual financial statements or detailed financial analysis included in the document. The document is essentially an announcement of the upcoming earnings call, not the earnings release itself or a transcript. Therefore, it fits best under the category of Call Transcript (CT) as it relates to a conference call event, but since it is only the schedule/intimation and not the transcript, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call, not the call transcript or earnings release itself.
2025-02-19 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter and nine months ended December 31, 2024. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and mentions newspaper clippings of the financial results being published. The document is dated February 11, 2025, and is signed by the Joint Managing Director and CFO. The content is an announcement of the publication of financial results, not the full financial report itself. The document length is about 15,000 characters, but the content is primarily an announcement of the newspaper publication of the unaudited quarterly and nine-month financial results, which fits the category of Regulatory Filings (RNS) as it is a regulatory announcement rather than the full Interim/Quarterly Report (IR).
2025-02-11 English
Intimation of Newspaper publication - Unaudited Financial Results (Standalone & Consolidated) for the Quarter and nine months ended December 31, 2024.
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter and nine months ended December 31, 2024. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, and mentions newspaper clippings of the financial results being published. The document is dated February 11, 2025, and is signed by the Joint Managing Director and CFO. The content is an announcement of the publication of financial results, not the full financial report itself. The document length is 15,000 characters, but the content is primarily an announcement with newspaper clipping extracts, not a comprehensive financial report with detailed financial statements or analysis. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement of financial results publication rather than the full report or earnings release.
2025-02-11 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.